There is no point trying to justify it by making a distinction between "market ready", "market readiness", or more recently "shelf ready". This is bullshit and you know it. We all expected that the so-called "PRODUCTS" the company claims to have would have hit the market by the 3rd quarter of this year.
Speaking of products, take another close look at the company's official website. The About Us section: http://www.owcpharma.com/about-us/ states that "We aim to produce pharmaceutical-grade cannabis-based products" . Meanwhile elsewhere on the site under the "PRODUCTS" section: http://www.owcpharma.com/our_products/ the words and tone implies that the company already has the products and that it is already a going concern. So don't tell us what Mordechai Bignitz said, may have said, or what he meant to say.
Read about "our products" and tell me where I can buy them. Or am I missing something here?
Speaking of products, take another close look at the company's official website. The About Us section: http://www.owcpharma.com/about-us/ states that "We aim to produce pharmaceutical-grade cannabis-based products" . Meanwhile elsewhere on the site under the "PRODUCTS" section: http://www.owcpharma.com/our_products/ the words and tone implies that the company already has the products and that it is already a going concern. So don't tell us what Mordechai Bignitz said, may have said, or what he meant to say.
Read about "our products" and tell me where I can buy them. Or am I missing something here?
Quote:OUR PRODUCTS
Cannabis Based Products
We develop cannabis based products targeting a variety of diseases and medical indications. We work to bring patients better outcomes by identifying unique formulation and efficient delivery systems.
Innovative Products
Our products represent major advancements in cannabis based treatment:
Each product has a known and standardized dosage of active ingredients. The amount of active ingredients is controlled, and the daily dose taken is easy to prescribe: it can be expressed as the number of dosage forms, (e.g. 1 tablet, twice a day) or volume of drug solution (e.g. 10mL);
The products undergo safety testing, preclinical (animal) testing and human (clinical) testing.
We ensure that each product under development meets specified requirements. We are committed to quality assurance and quality control;
We are committed to providing innovative products that help people live healthier.
Sublingual Soluble Tablets
With these tablets, we provide patients with an adequate alternative to smoking cannabis (marijuana) buds for the treatment and management of pain. These tablets can be sold and purchased worldwide – in countries and US states that have legalized use of the marijuana for medical purposes.
Topical Cream
Our topical (applied to skin only) cream treats various skin diseases, such as Psoriasis. The cream can be sold and purchased worldwide – in countries and US states that have legalized use of the marijuana for medical purposes.
5
